# ASCEND: A Study of Cardiovascular Events iN Diabetes

> **NCT00135226** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Oxford** · enrollment: 15480 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Omega-3 Ethyl Esters
- **DRUG:** Placebo Aspirin
- **DRUG:** Placebo Omega-3 Ethyl Esters

## Key facts

- **NCT ID:** NCT00135226
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2005-03
- **Primary completion:** 2018-03-12
- **Final completion:** 2037-07-31
- **Target enrollment:** 15480 (ACTUAL)
- **Last updated:** 2025-05-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135226, "ASCEND: A Study of Cardiovascular Events iN Diabetes". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00135226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*